Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Venture Life ( (GB:VLG) ) has provided an announcement.
Venture Life Group PLC has continued to execute its previously announced share buyback programme, repurchasing 29,300 ordinary shares at a volume-weighted average price of 68.00 pence per share through Cavendish Capital Markets Limited. The shares acquired will be held in treasury, reflecting the company’s ongoing capital management strategy.
Following this transaction, Venture Life has 128,860,145 ordinary shares in issue, of which 5,813,597 are held in treasury, leaving 123,046,548 voting rights outstanding. The updated share and voting-rights structure provides shareholders with an accurate denominator for regulatory disclosure calculations and may incrementally enhance earnings per share over time by reducing the free float.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group PLC is an international consumer self-care company focused on the global self-care market, particularly proactive healthy longevity. Headquartered in the UK, it markets products such as Balance Activ for women’s intimate health, Earol for ENT care, Lift and Glucogel for energy and glucose management, and Health & Her for hormonal lifecycle support.
Its products are typically recommended by pharmacists or healthcare practitioners and sold through health and beauty retailers, pharmacies, grocery multiples, and e-commerce channels worldwide. In the UK, Ireland and the U.S., Venture Life supplies retailers directly, while in other markets it relies on international distribution partners to reach consumers.
Average Trading Volume: 331,422
Technical Sentiment Signal: Buy
Current Market Cap: £82.46M
For detailed information about VLG stock, go to TipRanks’ Stock Analysis page.